Heart failure & cardiomyopathies

Systemic Inflammation is Associated with Myocardial Fibrosis in Patients with Obstructive Hypertrophic Cardiomyopathy

ESC Heart FailPublished Cross-sectional study

Authors' conclusion

Higher levels of IL-2 and TNF-α were associated with increased histopathological interstitial MF in patients with HCM.

Study context

Population
Patients with obstructive hypertrophic cardiomyopathy (HCM) undergoing septal myectomy with complete baseline data
Participants
102 patients
Exposure
High MF vs low MF; association of inflammatory markers with MF
Outcome
Association of plasma inflammatory markers with histopathological interstitial MF (Masson's trichrome)
Methodological detailshistopathological analysis of septal myectomy samples
  • Histopathological analysis of septal myectomy samples

Main finding

As reported in the abstract

Interstitial MF (histopathology), by inflammatory marker
Odds ratio (95% CI)P value
IL-2adjusted for age, sex and other clinical features
1.54(1.10–2.14)
IL-5adjusted for age, sex and other clinical features
1.42(1.02–1.98)
TNF-αadjusted for age, sex and other clinical features
1.33(1.04–1.70)
IL-2additionally adjusted for imaging indicators
1.49(1.06–2.09)
P = 0.021
TNF-αadditionally adjusted for imaging indicators
1.35(1.01–1.80)
P = 0.044

Observational data: associations, not effects.

Further findings

Plasma IL-2, tumour necrosis factor (TNF)-α and interferon (IFN)-α, high vs low MF

Significantly higher in high MF vs low MF: IL-2 (as printed)
2.3 vs. 4.0 pg/mL
TNF-α (as printed)
3.1 vs. 3.9 pg/mL
IFN-α (as printed)
4.2 vs.4.7 pg/mL
  • All P < 0.05

Overall MF

Range
2.5% to 40.7%
Mean ± SD
15.2 ± 8.1%
Median (IQR)
13.0% (9.9%-18.4%)

Late gadolinium enhancement (LGE) on CMR (replacement fibrosis)

LGE present
72 (74.2%) of 97
No significant correlation between inflammatory markers and presence or extent of LGE

Baseline characteristics, high vs low MF

High MF had larger left atrial diameter and LVEF

Original publication

Systemic Inflammation is Associated with Myocardial Fibrosis in Patients with Obstructive Hypertrophic Cardiomyopathy. ESC Heart Fail. Published 17 October 2024. doi:10.1002/ehf2.15109

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.